Skip to main content
Fig. 3B | BMC Infectious Diseases

Fig. 3B

From: Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis

Fig. 3B

The results of network meta-analysis for all-cause mortality and discontinuation due to adverse events

Note: Data are OR (95% CrI) of the row treatment relative to the column treatment in terms of all-cause mortality (orange) and discontinuation due to adverse events (blue). Bold values indicate comparisons that are statistically significant. ORs above 1 indicate higher risks of all-cause mortality and discontinuation due to adverse events.

Back to article page